Fresno patient one of the 1st in US to get new Alzheimer's treatment

FRESNO, Calif. (KFSN) -- A long-time Fresno doc is portion of a ground-breaking attraction successful the combat against Alzheimer's.

In July, the FDA approved Kisunla for radical with mild cognitive impairment and dementia.

On Monday, 1 of the archetypal patients successful the United States received the cause intravenously astatine the bureau of Dr. Perminder Bhatia successful northeast Fresno.

RELATED: Blood tests for Alzheimer's whitethorn beryllium coming to your doctor's office. Here's what to know

The neurologist says this caller attraction is not a cure, but it has proven to beryllium effectual successful slowing the progression of the disease.

For Dr. Bhatia, this attraction is particularly meaningful. His parent passed distant from Alzheimer's.

He says he's grateful to assistance supply his patients with a warring chance.

Kisunla is delivered by IV each 4 weeks.